A detailed history of Founders Financial Securities LLC transactions in Novartis Ag stock. As of the latest transaction made, Founders Financial Securities LLC holds 2,820 shares of NVS stock, worth $281,915. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,820
Previous 2,832 0.42%
Holding current value
$281,915
Previous $301,000 7.64%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$106.13 - $120.89 $1,273 - $1,450
-12 Reduced 0.42%
2,820 $324,000
Q2 2024

Aug 02, 2024

BUY
$92.57 - $107.37 $8,701 - $10,092
94 Added 3.43%
2,832 $301,000
Q1 2024

Apr 17, 2024

BUY
$95.27 - $108.47 $30,295 - $34,493
318 Added 13.14%
2,738 $264,000
Q4 2023

Feb 06, 2024

SELL
$92.27 - $101.54 $10,057 - $11,067
-109 Reduced 4.31%
2,420 $244,000
Q2 2023

Aug 11, 2023

BUY
$92.52 - $104.91 $27,756 - $31,473
300 Added 13.46%
2,529 $255,000
Q4 2022

Feb 08, 2023

BUY
$75.55 - $92.52 $168,400 - $206,227
2,229 New
2,229 $202,000
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $199,554 - $225,734
2,491 New
2,491 $219,000
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $181,306 - $210,925
-2,217 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$85.24 - $94.15 $188,977 - $208,730
2,217 New
2,217 $202,000
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $746,028 - $830,698
-10,128 Closed
0 $0
Q3 2018

Oct 17, 2018

BUY
$66.94 - $77.43 $5,622 - $6,504
84 Added 0.84%
10,128 $873,000
Q2 2018

Jul 18, 2018

SELL
$64.91 - $73.36 $1,428 - $1,613
-22 Reduced 0.22%
10,044 $759,000
Q1 2018

Apr 24, 2018

BUY
$70.39 - $84.15 $15,767 - $18,849
224 Added 2.28%
10,066 $814,000
Q4 2017

Jan 25, 2018

BUY
$72.33 - $77.64 $12,802 - $13,742
177 Added 1.83%
9,842 $826,000
Q3 2017

Nov 09, 2017

BUY
$74.14 - $77.27 $716,563 - $746,814
9,665
9,665 $830,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $215B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Founders Financial Securities LLC Portfolio

Follow Founders Financial Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Securities LLC with notifications on news.